
Eris Lifesciences Acquires Novartis’ Zomelis (vildagliptin) in India for $13M
Shots: Eris Lifesciences acquired Novartis’ novel therapy Zomelis for $13M (~INR 93 crore) and will initiate the commercialization of product from Dec 10,
[Read More...]